A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Incyte Corporation
Incyte Corporation
AstraZeneca
Endocyte
AIO-Studien-gGmbH
Ziekenhuis Oost-Limburg
UNICANCER
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)